Table 1.
Clinical Characteristics and C-reactive Protein of Kitavans and Swedish Controls with Samples Analyzed for C-reactive Protein
| Variable | Kitavans | Swedish controls | r | ||
|---|---|---|---|---|---|
| Male / female, n (%) | 61 (77%) / 18 (23%) | 58 (70%) / 25 (30%) | |||
| Smoker / non-smoker, n (%)** | 52 (69%) / 23 (31%) | 20 (24%) / 63 (76%) | 0.45 | ||
| Age, years M (SD) | 58 (11) | 60 (10) | |||
| Weight, kg M (SD)** | 48 (8) | 77 (13) | 0.83 | ||
| Height, cm M (SD)** | 159 (7) | 173 (9) | 0.65 | ||
| Body mass index, kg/m2 M (SD)** | 19 (2) | 26 (4) | 0.78 | ||
| Waist circumference, cm M (SD)** | 73 (5) | 89 (12) | 0.73 | ||
| Hip circumference, cm M (SD)** | 78 (5) | 101 (8) | 0.86 | ||
| Waist-hip ratio M(SD)** | 0.9 (0.0) | 0.9 (0.1) | 0.30 | ||
| Systolic blood pressure, mm Hg M (SD)** | 117 (17) | 136 (19) | 0.47 | ||
| Diastolic blood pressure, mm Hg M (SD)** | 70 (7) | 77 (9) | 0.42 | ||
| Fasting blood glucose, mmol/L M (SD)** | 3.8 (0.7) | 5.1 (1.3) | 0.64 | ||
| Fasting serum insulin, IU/mL M (SD)** | 4.7 (5.2) | 6.2 (6.1) | 0.28 | ||
| Total cholesterol, mmol/L M (SD)** | 5.0 (1.2) | 5.7 (1.0) | 0.31 | ||
| LDL, mmol/L M (SD)** | 3.4 (1.1) | 4.0 (0.9) | 0.33 | ||
| HDL, mmol/L M (SD)* | 1.0 (0.3) | 1.2 (0.3) | 0.18 | ||
| Triglyceride, mmol/L M (SD) | 1.2 (0.5) | 1.3 (0.8) | |||
| Non-HDL cholesterol, mmol/L M (SD)** | 4.0 (1.1) | 4.6 (0.9) | 0.28 | ||
| Total cholesterol-HDL ratio, mol/mol M (SD)a | 5.0 (1.4) | 5.2 (1.4) | |||
| LDL-HDL ratio, mol/mol M (SD)a | 3.4 (1.3) | 3.6 (1.1) | |||
| Triglyceride-HDL ratio, mol/mol M (SD)a | 1.3 (0.7) | 1.3 (1.1) | |||
| C-reactive protein, mg/L Mdn (range)* | 0.47 (0.14–48) | 1.10 (0.14–33) | 0.18 | ||
| C-reactive protein < 10, mg/L Mdn (range)* | 0.45 (0.14–8.2) | 0.96 (0.14–7.2) | 0.21 | ||
Note. LDL = low-density lipoprotein cholesterol. HDL = high-density lipoprotein cholesterol. a Values in mmol/L for ratios. * and ** p < .05 and p < .001, respectively